IGF1 and type 2 diabetes mellitus: Nevertheless, the relatively small sample sizes (ranging from around 50 to 800 cases) in previous studies and potential reverse causality, whereby the disease process caused changes in IGF-1 levels several years before the clinical diagnosis of type 2 diabetes, may have resulted in null or spurious findings.